Sunlink Health Systems Inc SSY
We take great care to ensure that the data presented and summarized in this overview for SUNLINK HEALTH SYSTEMS INC is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding SSY
View all-
Jim Simons Renaissance Technologies LLC | New York, Ny256KShares$153,8260.0% of portfolio
-
Bridgeway Capital Management, LLC Houston, TX218KShares$130,6800.0% of portfolio
-
Acadian Asset Management LLC Boston, MA164KShares$98,4500.0% of portfolio
-
Wittenberg Investment Management, Inc. Carlisle, MA87.6KShares$52,5390.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA83.9KShares$50,3650.0% of portfolio
-
Granite Investment Partners, LLC74.5KShares$44,7030.0% of portfolio
-
State Street Corp Boston, MA42.6KShares$25,5820.0% of portfolio
-
Geode Capital Management, LLC Boston, MA32.2KShares$19,3060.0% of portfolio
-
Ubs Group Ag10.1KShares$6,0450.0% of portfolio
-
Tower Research Capital LLC (Trc) New York, NY1.49KShares$8930.0% of portfolio
Latest Institutional Activity in SSY
Top Purchases
Top Sells
About SSY
SunLink Health Systems, Inc., through its subsidiaries, provides healthcare products and services in the southeastern United States. It operates through two segments, Healthcare Services and Pharmacy. The Healthcare Services segment owns and operates an 84-bed community hospital, which includes an 18-bed geriatric psychiatry unit; and a 66-bed extended care and rehabilitation center. This segment also provides information technology services; and owns unimproved lands. The Pharmacy segment offers institutional and non-institutional pharmacy services; and durable medical equipment products and services, including the sale and rental of products for institutional clients or to patients in institutional settings and patient-administered home care, as well as retails pharmacy products and services. SunLink Health Systems, Inc. was incorporated in 1959 and is based in Atlanta, Georgia.
Insider Transactions at SSY
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 24
2023
|
Howard E Turner Director |
BUY
Open market or private purchase
|
Direct |
1,000
+0.48%
|
$0
$0.97 P/Share
|
|
Oct 19
2023
|
Steven J Baileys Director |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
281,600
-100.0%
|
-
|
|
Oct 19
2023
|
Steven J Baileys Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
551,244
-100.0%
|
-
|
|
Oct 19
2023
|
Howard E Turner Director |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
28,219
-100.0%
|
-
|
|
Oct 19
2023
|
Howard E Turner Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
204,785
-100.0%
|
-
|
|
Oct 19
2023
|
Robert M Thornton Jr CEO, Chairman & President |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
559,562
-100.0%
|
-
|
|
Oct 19
2023
|
Mark J Stockslager CFO & Principal Acctg Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
108,051
-100.0%
|
-
|
|
Oct 19
2023
|
C Michael Ford Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
46,422
-100.0%
|
-
|
|
Oct 19
2023
|
Gene E Burleson Director |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
10,000
-100.0%
|
-
|
|
Oct 19
2023
|
Gene E Burleson Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
81,601
-100.0%
|
-
|
|
Aug 16
2023
|
Gene E Burleson Director |
BUY
Grant, award, or other acquisition
|
Indirect |
10,000
+50.0%
|
-
|
|
Aug 16
2023
|
Gene E Burleson Director |
BUY
Grant, award, or other acquisition
|
Direct |
81,601
+50.0%
|
-
|
|
Aug 16
2023
|
Howard E Turner Director |
BUY
Grant, award, or other acquisition
|
Indirect |
28,219
+50.0%
|
-
|
|
Aug 16
2023
|
Howard E Turner Director |
BUY
Grant, award, or other acquisition
|
Direct |
204,785
+50.0%
|
-
|
|
Aug 16
2023
|
Robert M Thornton Jr CEO, Chairman & President |
BUY
Grant, award, or other acquisition
|
Indirect |
559,562
+50.0%
|
-
|
|
Aug 16
2023
|
Mark J Stockslager CFO & Principal Acctg Officer |
BUY
Grant, award, or other acquisition
|
Direct |
108,051
+50.0%
|
-
|
|
Aug 16
2023
|
C Michael Ford Director |
BUY
Grant, award, or other acquisition
|
Direct |
46,422
+50.0%
|
-
|
|
Aug 16
2023
|
Steven J Baileys Director |
BUY
Grant, award, or other acquisition
|
Indirect |
281,600
+50.0%
|
-
|
|
Aug 16
2023
|
Steven J Baileys Director |
BUY
Grant, award, or other acquisition
|
Direct |
551,244
+50.0%
|
-
|
|
Sep 01
2022
|
C Michael Ford Director |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+30.11%
|
$20,000
$1.22 P/Share
|
Last 12 Months Summary
| Grant, award, or other acquisition | 1.87M shares |
|---|---|
| Open market or private purchase | 1K shares |
| Sale (or disposition) back to the issuer | 1.87M shares |
|---|